MacroGenics signs financial deal with Sagard for retifanlimab

Stock Information for MacroGenics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About MacroGenics Inc.

MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement
MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025
MacroGenics Provides Update on Corporate Progress and First Quarter 2025 Financial Results
MacroGenics Announces Date of First Quarter 2025 Financial Results
MacroGenics to Participate in Upcoming Investor Conference
MacroGenics Provides Update on Corporate Progress and 2024 Financial Results
MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call
MacroGenics to Participate in Upcoming Investor Conferences

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.